-
The Journal of Thoracic and... Mar 2022
Topics: Atrial Fibrillation; Catheter Ablation; Humans
PubMed: 32605734
DOI: 10.1016/j.jtcvs.2020.05.051 -
Heart Rhythm Dec 2022
Topics: Humans; Atrial Fibrillation; Adipose Tissue; Pericardium; Machine Learning
PubMed: 36041687
DOI: 10.1016/j.hrthm.2022.08.027 -
Open Heart Mar 2024There is an escalating trend in both the incidence and prevalence of atrial fibrillation (AF). AF is linked to numerous other comorbidities, contributing to the... (Review)
Review
There is an escalating trend in both the incidence and prevalence of atrial fibrillation (AF). AF is linked to numerous other comorbidities, contributing to the emergence of multimorbidity. The sustained rise in multimorbidity and AF prevalences exerts a significant strain on healthcare systems globally. The understanding of the relation between multimorbidity and AF is essential to determine effective healthcare strategies, improve patient outcomes to adequately address the burden of AF. It not only begins with the accurate identification of comorbidities in the setting of AF. There is also the need to understand the pathophysiology of the different comorbidities and their common interactions, and how multimorbidity influences AF perpetuation. To manage the challenges that rise from the increasing incidence and prevalence of both multimorbidity and AF, such as adverse events and hospitalisations, the treatment of comorbidities in AF has already gained importance and will need to be a primary focus in the forthcoming years. There are numerous challenges to overcome in the treatment of multimorbidity in AF, whereby the identification of comorbidities is essential. Integrated care strategies focused on a comprehensive multimorbidity management with an individual-centred approach need to be determined to improve healthcare strategies and reduce the AF-related risk of frailty, cardiovascular diseases and improve patient outcomes.
Topics: Humans; Atrial Fibrillation; Multimorbidity; Comorbidity; Hospitalization; Frailty
PubMed: 38508658
DOI: 10.1136/openhrt-2024-002641 -
Vascular Health and Risk Management 2016Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, and it places a substantial burden on the health care system. Despite... (Review)
Review
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, and it places a substantial burden on the health care system. Despite improvements in our understanding of AF pathophysiology, we have yet to develop targeted preventive therapies. Recently, numerous biological markers have been identified to aid in the prediction of future AF events. Subclinical markers of atrial stress, inflammation, endothelial dysfunction, kidney dysfunction, and atherosclerosis have been linked to AF. The connection between these markers and AF is the identification of subclinical states in which AF propagation is likely to occur, as these conditions are associated with abnormal atrial remodeling and fibrosis. Additionally, several risk scores have been developed to aid in the identification of at-risk patients. The practicing clinician should be aware of these subclinical markers, as several of these markers improve the predictive abilities of current AF risk scores. Knowledge of these subclinical markers also provides clinicians with a better understanding of AF risk factors, and the opportunity to reduce the occurrence of AF by incorporating well-known cardiovascular disease risk factor modification strategies. In this review, we highlight several novel biological markers that have improved our understanding of AF pathophysiology and appraise the utility of these markers to improve our ability to predict future AF events.
Topics: Animals; Atrial Fibrillation; Biomarkers; Humans; Predictive Value of Tests; Prognosis; Risk Factors
PubMed: 27486329
DOI: 10.2147/VHRM.S75537 -
JACC. Cardiovascular Interventions Sep 2020
Topics: Atrial Appendage; Atrial Fibrillation; Echocardiography, Transesophageal; Humans; Treatment Outcome
PubMed: 32972571
DOI: 10.1016/j.jcin.2020.06.029 -
Hellenic Journal of Cardiology : HJC =... 2016
Topics: Acute Coronary Syndrome; Adult; Age Factors; Aged; Aged, 80 and over; Atrial Fibrillation; Disease Management; Europe; Female; Humans; Incidence; Male; Middle Aged
PubMed: 27445033
DOI: 10.1016/j.hjc.2016.05.001 -
Cardiovascular Therapeutics Oct 2014Atrial fibrillation (AF) has been defined as the new cardiovascular "epidemic". Its prevalence is rising in developed countries, and the associated social and economic... (Review)
Review
Atrial fibrillation (AF) has been defined as the new cardiovascular "epidemic". Its prevalence is rising in developed countries, and the associated social and economic costs are high. In the last few years, there has been an increasing interest in understanding the mechanisms of AF and its management. New pharmacotherapies together with novel techniques for surgical and catheter treatment of AF have been developed, allowing the maintenance of sinus rhythm and the alleviation of symptoms in a large number of patients with AF. However, there are still some challenges that need to be addressed. This article gives an overview of the current state of the art on novel techniques for diagnosis and management of AF.
Topics: Atrial Fibrillation; Catheter Ablation; Electric Countershock; Humans; Minimally Invasive Surgical Procedures; Sternotomy; Thromboembolism
PubMed: 25130510
DOI: 10.1111/1755-5922.12090 -
Lakartidningen Jan 2018The ABC of atrial fibrillation at the emergency care department Atrial fibrillation (AF) is the most common tachyarrhythmia. When handling patients with AF at the...
The ABC of atrial fibrillation at the emergency care department Atrial fibrillation (AF) is the most common tachyarrhythmia. When handling patients with AF at the emergency care department it is of utmost importance to take a structural approach, make the right diagnosis, take care of the risk and/or trigger factors, treat and make sure there is an adequate follow-up.
Topics: Aftercare; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Disease Management; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Humans; Risk Assessment
PubMed: 29360132
DOI: No ID Found -
Ugeskrift For Laeger Feb 2022Smartwatches can contribute to increased physical activity and weight loss in chronic patient groups, especially when included as a subcomponent in a bigger lifestyle... (Review)
Review
Smartwatches can contribute to increased physical activity and weight loss in chronic patient groups, especially when included as a subcomponent in a bigger lifestyle intervention. ECGs from smartwatches can most likely be used to screen for atrial fibrillation in general practice. However, there is yet no definitive clinical validation and systematic studies on the possible consequences of using smartwatches. Access to more reliable health data in the patient's home may be the key to better health for chronic patients. Digital monitoring could become an important aspect of future health care, as argued in this review.
Topics: Atrial Fibrillation; Electrocardiography; Humans
PubMed: 35244021
DOI: No ID Found -
JACC. Cardiovascular Interventions Dec 2022
Topics: Humans; Atrial Fibrillation; Treatment Outcome
PubMed: 36480990
DOI: 10.1016/j.jcin.2022.09.059